Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 422" (RNA5SP422) is a processed pseudogene of the 5S ribosomal RNA (5S rRNA) gene. The canonical 5S rRNA is a 120-nucleotide structural RNA crucial for large ribosomal subunit assembly and function, but pseudogenes like RNA5SP422 arise through retrotransposition or duplication and are generally non-functional owing to inactivating mutations or lack of regulatory elements[2][3][6]. While canonical 5S rRNA is indispensable for protein synthesis in all domains of life[1][3], the pseudogene RNA5SP422 does not encode a functional RNA and is not considered a therapeutic target. Some pseudogenes have been shown to exert regulatory effects (e.g., acting as miRNA decoys or antisense RNAs[2][4]), but there is currently no evidence that RNA5SP422 has such functions or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 422 (RNA5SP422).